Response to Comment on Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.

Lipsky, Andrew H; Lozier, Jay N; Wiestner, Adrian

Lipsky, Andrew H; Lozier, Jay N; Wiestner, Adrian.

Afiliación

Lipsky AH; Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD Department of Internal Medicine, Montefiore Medical Center, Bronx, New York, NY, USA.
Lozier JN; Department of Laboratory Medicine, NIH Clinical Center, Bethesda, MD.
Wiestner A; Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD wiestnea@nhlbi.nih.gov.

Haematologica ; 101(3): e124-5, 2016 Mar.

Article en En | MEDLINE | ID: mdl-26928253

Asunto(s)

Hemorragia; Leucemia Linfocítica Crónica de Células B; Humanos; Incidencia; Factores de Riesgo

Palabras clave

chronic lymphocytic leukemia; disorders of platelet function; laboratory hematology

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Hemorragia Tipo de estudio: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google